Mary Wu

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

Authors (62)

Annika Fendler
Scott Shepherd
Lewis Au
Mary Wu
Ruth Harvey
Andreas M Schmitt
[...]
Emma Nicholson
Susanna Walker
James Larkin
Samra Turajlic
The CAPTURE consortium

The Lancet

Published 25 January 2022

Crick labs/ facilities

Full details

Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients

Authors (19)

Edward J Carr
Mary Wu
Ruth Harvey
Roseanne E Billany
Emma C Wall
Gavin Kelly
[...]
Rachel B Jones
Rona M Smith
Stephen McAdoo
Michelle Willicombe
Rupert Beale

The Lancet

Published 20 January 2022

Crick labs/ facilities

Full details

Three-dose vaccination elicits neutralising antibodies against omicron

Authors (26)

Mary Wu
Emma C Wall
Edward J Carr
Ruth Harvey
Hermaleigh Townsley
Harriet Mears
[...]
Vincenzo Libri
Bryan Williams
Sonia Gandhi
Charles Swanton
David LV Bauer

The Lancet

Published 19 January 2022

Crick labs/ facilities

Full details

Functional profiling of long intergenic non-coding RNAs in fission yeast

Authors (15)

Maria Rodriguez-Lopez
Shajahan Anver
Cristina Cotobal
Stephan Kamrad
Michal Malecki
Clara Correia Melo
[...]
Mary Wu
Luis Montemayor
Michael Howell
Markus Ralser
Jürg Bähler

eLife

Published 5 January 2022

Crick labs/ facilities

Full details

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

Authors (65)

Annika Fendler
Scott Shepherd
Lewis Au
Katalin Wilkinson
Mary Wu
Andreas M Schmitt
[...]
Susanna Walker
Robert Wilkinson
James Larkin
Samra Turajlic
CAPTURE consortium

Cancer Cell

Published 29 December 2021

Crick labs/ facilities

Full details

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Authors (98)

Nature Cancer

Published 1 December 2021

Crick labs/ facilities

Full details

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Authors (98)

Nature Cancer

Published 1 December 2021

Crick labs/ facilities

Full details

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

Authors (89)

Nature Cancer

Published 1 December 2021

Crick labs/ facilities

Full details

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

Authors (86)

Edward J Carr
Mary Wu
Ruth Harvey
Emma C Wall
Gavin Kelly
Saira Hussain
[...]
Emma Russell
Andy Riddell
Svend Kjaer
Annabel Borg
Chloe Roustan

The Lancet

Published 18 September 2021

Crick labs/ facilities

Full details

Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains

Authors (30)

Nikhil Faulkner
Kevin Ng
Mary Wu
Ruth Harvey
Marios Margaritis
Stavroula Paraskevopoulou
[...]
Michael Howell
David LV Bauer
Eleni Nastouli
SAFER Investigators
George Kassiotis

eLife

Published 29 July 2021

Crick labs/ facilities

Full details

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease

Authors (14)

Biochemical Journal

Published 16 July 2021

Crick labs/ facilities

Full details

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase

Authors (12)

Biochemical Journal

Published 16 July 2021

Crick labs/ facilities

Full details

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease

Authors (22)

Biochemical Journal

Published 16 July 2021

Crick labs/ facilities

Full details

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease

Authors (19)

Biochemical Journal

Published 16 July 2021

Crick labs/ facilities

Full details

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase

Authors (21)

Saz Basu
Tiffany Mak
Rachel Ulferts
Mary Wu
Tom Deegan
Ryo Fujisawa
[...]
Rupert Beale
Victoria H Cowling
Michael Howell
Karim Labib
John Diffley

Biochemical Journal

Published 16 July 2021

Crick labs/ facilities

Full details

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease

Authors (19)

Biochemical Journal

Published 16 July 2021

Crick labs/ facilities

Full details

AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC

Authors (24)

Emma C Wall
Mary Wu
Ruth Harvey
Gavin Kelly
Scott Warchal
Chelsea Sawyer
[...]
Vincenzo Libri
Bryan Williams
Charles Swanton
Sonia Gandhi
David LV Bauer

Lancet

Published 17 July 2021

Crick labs/ facilities

Full details

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

Authors (25)

Emma C Wall
Mary Wu
Ruth Harvey
Gavin Kelly
Scott Warchal
Chelsea Sawyer
[...]
Vincenzo Libri
Bryan Williams
Charles Swanton
Sonia Gandhi
David LV Bauer

The Lancet

Published 19 June 2021

Crick labs/ facilities

Full details

Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome

Authors (18)

Valeria Lulla
Michal P Wandel
Katarzyna J Bandyra
Rachel Ulferts
Mary Wu
Tom Dendooven
[...]
William Scott
Yiliang Ding
Andrew E Firth
Kotryna Bloznelyte
Ben F Luisi

Journal of Virology

Published 1 July 2021

Crick labs/ facilities

Full details

Coronavirus (COVID-19) response

Vacancies

Outwitting Cancer

Coronavirus (COVID-19) research

About us

Mary Wu

PRINCIPAL LABORATORY RESEARCH SCIENTIST

High Throughput Screening

Year published

Research topics

Publication type

Journal

Crick Pre-Crick

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients

Three-dose vaccination elicits neutralising antibodies against omicron

Functional profiling of long intergenic non-coding RNAs in fission yeast

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease

AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome

The Francis Crick Institute is a unique partnership between